PDCD1 and neoplasm: Though PD-L1 expression correlates with intensified tumor growth and invasiveness, which is associated with adverse prognosis [115,116,117], the presence of PD-L1 within the tumor microenvironment predicts a better clinical response to PD-1/PD-L1 checkpoint blockade therapy [17,118].